Annual SGA
$53.37 M
+$32.74 M+158.77%
December 31, 2023
Summary
- As of February 7, 2025, SCPH annual SGA is $53.37 million, with the most recent change of +$32.74 million (+158.77%) on December 31, 2023.
- During the last 3 years, SCPH annual SGA has risen by +$41.59 million (+352.89%).
- SCPH annual SGA is now at all-time high.
Performance
SCPH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$21.32 M
+$3.81 M+21.77%
September 30, 2024
Summary
- As of February 7, 2025, SCPH quarterly SGA is $21.32 million, with the most recent change of +$3.81 million (+21.77%) on September 30, 2024.
- Over the past year, SCPH quarterly SGA has increased by +$5.08 million (+31.26%).
- SCPH quarterly SGA is now at all-time high.
Performance
SCPH Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.24 B
-$80.11 M-6.93%
September 30, 2024
Summary
- As of February 7, 2025, SCPH TTM SGA is -$1.24 billion, with the most recent change of -$80.11 million (-6.93%) on September 30, 2024.
- Over the past year, SCPH TTM SGA has dropped by -$1.29 billion (-2417.81%).
- SCPH TTM SGA is now -2763.48% below its all-time high of -$43.20 million.
Performance
SCPH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SCPH Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +158.8% | +31.3% | -2417.8% |
| 3 y3 years | +352.9% | +197.1% | -6097.5% |
| 5 y5 years | +289.0% | +197.1% | -6097.5% |
SCPH Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +445.5% | at high | +873.1% | -72.6% | at low |
| 5 y | 5-year | at high | +545.1% | at high | +908.0% | -165.6% | at low |
| alltime | all time | at high | +1971.0% | at high | +2160.9% | -2763.5% | at low |
ScPharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $21.32 M(+21.8%) | $72.52 M(+11.0%) |
| Jun 2024 | - | $17.51 M(+0.3%) | $65.33 M(+9.0%) |
| Mar 2024 | - | $17.45 M(+7.4%) | $59.92 M(+12.3%) |
| Dec 2023 | $53.37 M(+158.8%) | $16.24 M(+14.9%) | $53.37 M(+20.5%) |
| Sep 2023 | - | $14.13 M(+16.9%) | $44.30 M(+21.6%) |
| Jun 2023 | - | $12.10 M(+11.0%) | $36.45 M(+27.3%) |
| Mar 2023 | - | $10.90 M(+51.8%) | $28.63 M(+38.8%) |
| Dec 2022 | $20.62 M(+110.8%) | $7.18 M(+14.3%) | $20.63 M(+31.9%) |
| Sep 2022 | - | $6.28 M(+46.7%) | $15.64 M(+35.1%) |
| Jun 2022 | - | $4.28 M(+47.9%) | $11.57 M(+16.4%) |
| Mar 2022 | - | $2.89 M(+32.0%) | $9.94 M(+1.6%) |
| Dec 2021 | $9.78 M(-17.0%) | $2.19 M(-0.9%) | $9.78 M(-11.2%) |
| Sep 2021 | - | $2.21 M(-16.5%) | $11.02 M(-9.1%) |
| Jun 2021 | - | $2.65 M(-3.0%) | $12.13 M(+0.9%) |
| Mar 2021 | - | $2.73 M(-20.2%) | $12.01 M(+1.9%) |
| Dec 2020 | $11.78 M | $3.42 M(+3.2%) | $11.78 M(+12.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $3.32 M(+30.8%) | $10.47 M(+14.5%) |
| Jun 2020 | - | $2.54 M(+1.4%) | $9.15 M(+8.3%) |
| Mar 2020 | - | $2.50 M(+18.3%) | $8.45 M(+2.2%) |
| Dec 2019 | $8.27 M(-39.7%) | $2.12 M(+6.0%) | $8.27 M(+0.5%) |
| Sep 2019 | - | $2.00 M(+8.5%) | $8.23 M(+0.6%) |
| Jun 2019 | - | $1.84 M(-20.8%) | $8.18 M(-28.2%) |
| Mar 2019 | - | $2.32 M(+12.0%) | $11.39 M(-17.0%) |
| Dec 2018 | $13.72 M(+50.7%) | $2.07 M(+6.6%) | $13.72 M(-6.3%) |
| Sep 2018 | - | $1.95 M(-61.5%) | $14.64 M(+2.0%) |
| Jun 2018 | - | $5.05 M(+8.6%) | $14.36 M(+22.9%) |
| Mar 2018 | - | $4.65 M(+55.4%) | $11.68 M(+28.3%) |
| Dec 2017 | $9.11 M(+50.4%) | $2.99 M(+79.7%) | $9.11 M(+29.0%) |
| Sep 2017 | - | $1.67 M(-29.9%) | $7.06 M(+30.9%) |
| Jun 2017 | - | $2.37 M(+14.5%) | $5.39 M(+78.7%) |
| Mar 2017 | - | $2.07 M(+119.9%) | $3.02 M(+219.9%) |
| Dec 2016 | $6.05 M(+134.9%) | $943.00 K | $943.00 K |
| Dec 2015 | $2.58 M | - | - |
FAQ
- What is scPharmaceuticals annual SGA?
- What is the all time high annual SGA for scPharmaceuticals?
- What is scPharmaceuticals annual SGA year-on-year change?
- What is scPharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for scPharmaceuticals?
- What is scPharmaceuticals quarterly SGA year-on-year change?
- What is scPharmaceuticals TTM SGA?
- What is the all time high TTM SGA for scPharmaceuticals?
- What is scPharmaceuticals TTM SGA year-on-year change?
What is scPharmaceuticals annual SGA?
The current annual SGA of SCPH is $53.37 M
What is the all time high annual SGA for scPharmaceuticals?
scPharmaceuticals all-time high annual SGA is $53.37 M
What is scPharmaceuticals annual SGA year-on-year change?
Over the past year, SCPH annual SGA has changed by +$32.74 M (+158.77%)
What is scPharmaceuticals quarterly SGA?
The current quarterly SGA of SCPH is $21.32 M
What is the all time high quarterly SGA for scPharmaceuticals?
scPharmaceuticals all-time high quarterly SGA is $21.32 M
What is scPharmaceuticals quarterly SGA year-on-year change?
Over the past year, SCPH quarterly SGA has changed by +$5.08 M (+31.26%)
What is scPharmaceuticals TTM SGA?
The current TTM SGA of SCPH is -$1.24 B
What is the all time high TTM SGA for scPharmaceuticals?
scPharmaceuticals all-time high TTM SGA is -$43.20 M
What is scPharmaceuticals TTM SGA year-on-year change?
Over the past year, SCPH TTM SGA has changed by -$1.29 B (-2417.81%)